Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

FHC Group acquires Activo Health to expand in Africa

PRIVATESep 08, 2026about 2 hours ago

Acquiring Company

FHC Group

Acquired Company

Activo Health

PortugalSouth AfricaBiotechnologyPharmaceuticalBiotechnologyHealth CarePharmaceutical

Description

FHC Group has acquired Activo Health from Afrocentric to enhance its presence in Africa, emphasizing sterile injectables. The deal included an upfront payment of R100m and future performance-based earn-outs. FHC plans to establish a manufacturing facility in South Africa, leveraging the country's stable regulatory environment.

Company Information

Company

FHC Group

Location

Portugal

About

FHC is a privately held Portuguese pharmaceutical group that owns Laboratórios Basi. It reported a turnover of about €543m in 2025. The company focuses on strengthening its presence in Africa and expanding its pharmaceutical offerings.

Don't miss FHC Group's next move

Get an email the moment FHC Group makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for FHC Group's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Activo Health?

Activo Health was acquired by FHC Group, based in Portugal. The deal was reported on September 8, 2026. FHC is a privately held Portuguese pharmaceutical group that owns Laboratórios Basi. It reported a turnover of about €543m in 2025. FHC Group is privately held and operates in Biotechnology.

When did FHC Group acquire Activo Health?

FHC Group's acquisition of Activo Health was reported on September 8, 2026. FHC Group has acquired Activo Health from Afrocentric to enhance its presence in Africa, emphasizing sterile injectables. The deal included an upfront payment of R100m and future performance-based earn-outs. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Activo Health do?

Activo Health is a pharmaceutical company that sells a range of nonprescription products. It has recently begun bidding for state contracts and currently supplies several medicines to the state. It is privately held, operating in Biotechnology, and is based in South Africa.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.